Oculis Holding AG OCS
NASDAQ OCS
$12.17 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Oculis Holding AG (OCS) Amortizatization of Intangibles (2022 - 2024)

Analysis

Oculis Holding AG (OCS) Amortizatization of Intangibles (2022 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.33 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 678,000.00
10 Oculis Holding AG 634.75 Mn 345.87 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 50,410.02
Dec 31, 2023 50,730.95
Sep 30, 2023 49,814.71
Jun 30, 2023 50,047.90
Mar 31, 2023 30,272.55
Dec 31, 2022 45,672.96
Sep 30, 2022 42,453.72